Endocarditis was produced in rabbits with a methicilhin-resistant Staphylococcus epidernidis isolate. Subpopulations resistant to other semisynthetic penicillins and cephalosporins were detected in the isolate. Their presence was probably responsible for the increase in minimum bactericidal concentrations and miimum inhibitory concentrations when tests with high inocula, rather than low inocula were pursued. Rabbits were treated for either 2 or 7 days with nafcillin, cephalothin, cefamandole, vancomycin, rifampin, or gentamicin. Spontaneous death was uncommon in either controls (84% survival) or treated animals (80 to 94% survival). There was no significant difference in the number of bacteria in vegetations of rabbits treated for 7 days with cephalothin, cefamandole, nafcillin, or no antibiotic (control). There was a significant reduction in total bacteria in vegetations of rabbits given vancomycin, gentamicin, or rifampin for 7 days as compared with cephalothin, cefamandole, nafcillin or control. Gentamicin or rifampin sterilized significantly more vegetations after 7 days than cephalothin, cefamandole, nafcillin, or control; rifampin was more effective in sterilizing vegetations than either gentamycin or vancomycin after 2 days. Mutants resistant to 10 ug of rifampin per ml comprised the total bacterial population cultured from vegetations of 2 of 17 rabbits treated with this antibiotic for 7 days; there was no change in the susceptibility of vegetation isolates to other antibiotics. Rifampin, vancomycin, or gentamicin may prove to be more effective in humans than cephalosporins or semisynthetic penicillins in the treatment of methicillin-resistant S. epidermidis endocarditis.
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The development of prosthetic valve endocarditis (PVE) is one of the most serious complications after the placement of an artificial heart valve. Mortality rates of over 60% have been reported, and many of the survivors have required removal of the infected prosthesis with reimplantation of a new valve for eradication of the infection (10, 12) . Staphylococcus epidermidis is the most common organism causing PVE, being responsible for over one-third of the cases (6 PVE, a rabbit model of experimental endocarditis was used. The following study evaluated the relative therapeutic efficacy of these antibiotics as assessed by a reduction in bacterial density and the selection of resistant bacterial populations in infected vegetations.
MATERIAILS AND METHODS
Production of endocarditis. Endocarditis was produced by a modification of previously described methods (3). A 19-gauge polyethelene catheter (Deseret Co., Salt Lake City, Utah) was introduced through the carotid artery into the left ventricle of 2-kg New Zealand white rabbits. The catheter, with its inner metal guide wire, was left in place for the entire study period so as to more closely simulate a rigid intracardiac prosthesis. Seventy-two hours after catheterization, the animals were challenged intravenously with a 1-ml suspension containing an average of 1010.1 (range, In vitro testing. The minimum inhibitory and bactericidal concentrations of the methicillin-resistant S. epidermidis to gentamicin, rifampin, vancomycin, nafcillin, cefamandole, and cephalothin were determined in triplicate by the microtiter method with inoculum sizes of 105 and 107 CFU/ml with MuellerHinton broth (Difco Laboratories, Detroit, Mich.) as the diluent. Each minimal inhibitory concentration was read after 24 h of incubation at 37°C, and then 0.01 ml was subcultured from wells containing the lower inoculum or 0.001 ml was subcultured from wells containing the higher inoculum. After 48 h of incubation at 370C, 99.9% kill was determined as the lowest antibiotic concentration yielding no growth on subculture of the wells containing the lower inoculum and <10 colonies from wells containing the higher inoculum.
The presence of resistant subpopulations in the challenge isolate was detected by plating 109 organisms grown overnight in Mueller-Hinton broth on MuellerHinton agar plates containing twofold dilutions of the antibiotic to be studied. Antibiotic concentrations ranged from the minimal inhibitory concentrations for the respective antibiotics to 100 ug/ml. Plates were incubated at 370C for 72 h. Resistant subpopulations in the vegetations of both treated and untreated rabbits were sought by spreading 0.1 ml of homogenized vegetation on agar plates containing the antibiotic which that rabbit had received as therapy. The following concentrations were used for testing isolates from infected vegetations: nafcillin, cephalothin, cefamandole, or vancomycin, 20 ,ug/ml; rifampin, 10 ,rg/ml; and gentamicin, 5 ,ug/ml. Antibiotic serum concentrations were measured by the agar disk diffusion assay with either Sarcina lutea ATCC 9341 (rifampin) or Bacillus subtilis ATCC 6633 (gentamicin, vancomycin, nafcillin, cephalothin, and cefamandole) as the indicator organism as previously described (2). Serum samples for antibiotic concentration were obtained on day 3 of therapy at intervals after the administration of the drugs as shown in Table   2 .
Serum samples for measuring bactericidal titers were also obtained on day 3 of therapy at the peak of antibiotic activity. This was 0.5 h after the administration of cephalothin, cefamandole, nafcillin, vancomycin, or gentamicin and 2 h after the dose of rifampin. Titers were determined in triplicate by the microtiter twofold dilution method with inoculum sizes of 105 and 107 CFU/ml with rabbit serum as the diluent. Subculture of 0.01 ml from microtiter wells containing the lower inoculum and 0.001 ml from the wells with the higher inoculum to Mueller-Hinton agar was performed after incubation for 24 h at 370C. The bactericidal titers (99.9% kill) were read as the highest dilution of serum that resulted in no growth on agar after 48 h of incubation for the lower inoculum or <10 colonies on agar for the higher inoculum.
RESULTS
The minimum inhibitory concentFations and miniimum bactericidal concentrations of the antibiotics against the S. epidermidis isolate at the two inoculum sizes are shown in Table 1 cephalosporins at the high as compared with the low inoculum, whereas there was no more than a twofold difference due to inoculum size with rfampin, gentamicin, or vancomycin. Table 2 shows the antibiotic dosages and mean serum antibiotic concentrations at the times indicated after injection. These serum levels are similar to those obtained in humans.
A total of 158 rabbits were included in the study. The ess was not confined to the valve leaflets; both the valve ring and myocardium were also involved.
The percentage of control rabbits surviving the 11 days between challenge and sacrifice was 84%. The survival of treated rabbits was similar, varying from 80% (nafcillin) to 92% (gentamicin). There were no statisticaUly significant differences in survival among these groups (P > 0.05, Fisher's exact test).
The effect of 7 days of therapy on bacterial density in infected vegetations is illustrated in Fig. 1 . There was no significant difference between the number of bacteria in vegetations of control rabbits and those given either nafcillin, cephalothin, or cefamandole (P > 0.05; Wilcoxon rank sum test). There was a ignificant reduction in the number of CFU of S. epidermidis per gram of vegetation in rabbits treated with either In two out of three rabbits treated for 7 days with rifampin and with refractory infection, the total bacterial population in the vegetation was resistant to 10 iLg of the antibiotic per ml. Rabbits receiving nafcillin had resistant subpopulations in vegetations but no subpopulations resistant to gentamicin, vancomycin, cephalothin, or cefamandole were detected. However, subpopulations resistant to nafcillin occurred with the same frequency in vegetations that they did in the challenge inoculum.
The median and range of the serum bactericidal titers are shown in Table 3 . Rabbits treated with either gentamicin or rifampin demonstrated the highest median titers. Although a median peak titer of at least 1:8 was seen in rabbits treated with cephalothin, cefamandole, or nafcillin at the lower inoculum, a high inoculum resulted in a fall in titer of at least three dilutions for every rabbit. This fall in titer was not seen in rabbits treated with rifampin, gentamicin, or vancomycm.
A group of 39 rabbits was treated with either gentamicin, rifampin, or vancomycin for 2 days Gentamicin, rifampin, or vancomycin given for 7 days were significantly more effective than nafcillin or cephalosporins in reducing the number of bacteria in vegetation tissue. These findings are in agreement with in vitro data showing that these three agents are the most active antibiotics against methicillin-resistant S. epidermidis and that nafcillin selects resistant subpopulations while the bacteria are exposed to the drug (2). The reasons for failure of therapy with cephalosporins are not clear. There are several possible explanations. First, there was a long interval between cephalosporin doses with unmeasurable antibiotic levels. However, there were equally long antibiotic-free intervals in animals given gentamicin or vancomycin yet therapy with these antibiotics was successful. Second, subpopulations resistant to cephalothin and cefamandole were present in the challenge isolate. Even though no cephalosporin-resistant subpopulations were detected in infected vegetations after therapy, it is possible that resistant subpopulations were selected during exposure to the drug and reverted to the parent phenotype when the drug concentration in the serum decreased. The reversion of methicillin-resistant S. epidermidis isolates to their parent phenotype occurs after selection ofsernisynthetic penicillinresistant subpopulations if the inducing antibiotic is removed (2).
Mutants highly resistant to rifampin emerge rapidly when S. epidermidis are incubated in rifampin-containing broth (2). In our study, two out of three rabbits with persistent infection after rifampin therapy had endocarditis with rifampin-resistant mutants. However, these were the only 2 of 17 rabbits treated with rifampin for 7 days which had resistant organisms after therapy. The low incidence of rifampinresistant S. epidermidis endocarditis may suggest either that mutants are less virulent than the wild isolate or that the number of organisms in the vegetations was low enough so that mutants occurring at a low frequency would not be selected by therapy. It has been shown in vitro that rifampin-resistant S. epidermidis mutants are found at a frequency of approximately one per 107 bacteria (2). This low rifampin resistance frequency was also found in our challenge isolate.
Treatment for only 2 days showed that rifampin was more rapidly effective than either gentamicin or vancomycin; 8 of 12 (67%) animals receiving rifampin had sterile vegetations after 48 h whereas only 3 of 11 (27%) rabbits treated ANTIMICROB. AGENTS CHEMOTHER.
with vancomycin and 1 of 10 (10%) given gentamicin had sterile vegetations. The greater efficacy of rifampin was possibly due to the low minimum bactericidal concentration ofthis antibiotic for S. epiderrnidis, the persistence of therapeutic rifampin blood levels (mean, 1.7 itg/ml) 12 h after a dose, and the ready diffusability of rifampin into tissue and body fluids (1, 7).
Rabbits freated with gentamicin or rifampin had the highest median peak serum bactericidal titers at both low and high inoculum sizes, and this correlated with therapeutic efficacy. Although all the treatment groups had median titers of 1:8 at the lower bacterial inoculum size, rabbits given the cephalospoins or nafcillin had at least an eightfold decrease in titer when serum was incubated with the higher inoculum of S. epidermidis such that no rabbit had a peak bactericidal titer of >1:4. Serum bactericidal titers in humans with S. epidermidis PVE should probably be performed with both a high and a low inoculum size to minimize this inoculum effect.
Because higher seumn antibiotic levels can be maintained in humans by more frequent dosing than was possible in this study, our results showed only relative antibiotic efficacy for the treatment ofmethicillin-resistant S. epidernnidis endocarditis. However, in view of the superiority demonstrated by gentamicin, rifampin, or vancomycin over nafcillin or cephalosporins, these antibiotics should be considered for initial therapy in the treatment of human S. epidernidis PVE. This is particularly true in view of the dismal results obtained in humans by using conventional therapy and the encouraging early successes achieved with the use of rifampin for treating patients with S. epidernidis PVE (4, 8) .
